Adjunctive Rifampin for the Treatment of Prosthetic Valve Endocarditis Due to S. Aureus

NCT07253688 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

330

Enrollment

OTHER

Sponsor class

Conditions

Staphylococcus Aureus Endocarditis
Prosthetic Valve Endocarditis

Interventions

DRUG: Rifampin
OTHER: No rifampin

Sponsor

Todd C. Lee MD MPH FIDSA

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]